dactinomycin has been researched along with E coli Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, JH; Kim, KS; Kuzmenko, A; McCormack, FX; Schaffer, L; Wan, S; Weiss, A; Wu, H | 1 |
| Ikawa, K; Ikeda, K; Mikamo, H; Morikawa, N; Tamaya, T | 1 |
| Dohmen, K; Irie, K; Ishibashi, H; Miyamoto, Y; Onohara, S; Shimada, T; Shirahama, M | 1 |
3 other study(ies) available for dactinomycin and E coli Infections
| Article | Year |
|---|---|
Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability.
Topics: Animals; Bacterial Outer Membrane Proteins; Bronchoalveolar Lavage Fluid; Cell Division; Cell Membrane Permeability; Collectins; Dactinomycin; Escherichia coli; Escherichia coli Infections; Fluorescent Dyes; Genetic Predisposition to Disease; Gram-Negative Bacteria; Humans; Mice; Mice, Inbred C3H; Mice, Knockout; Microbial Sensitivity Tests; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Protein D; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections | 2003 |
Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate.
Topics: Anti-Bacterial Agents; Area Under Curve; Cefozopran; Cephalosporins; Escherichia coli; Escherichia coli Infections; Exudates and Transudates; Female; Humans; Hysterectomy; Lymph Node Excision; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Pelvis; Postoperative Complications; Retroperitoneal Space | 2008 |
Obstructive jaundice due to multiple hepatic abscesses.
Topics: Bacteroides Infections; Cefozopran; Cephalosporins; Cholestasis; Drainage; Escherichia coli Infections; Humans; Infusions, Intravenous; Klebsiella Infections; Liver Abscess; Male; Middle Aged | 1998 |